Revolution Medicines, Inc. RVMD Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s earnings yield?
- Revolution Medicines, Inc. (RVMD) reported earnings yield of -7.1% in Q1 2026.
- How has Revolution Medicines, Inc.'s earnings yield changed year-over-year?
- Revolution Medicines, Inc.'s earnings yield increased by 32.9% year-over-year, from -10.6% to -7.1%.
- What is the long-term trend for Revolution Medicines, Inc.'s earnings yield?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s earnings yield has grown at a 9.0% compound annual growth rate (CAGR), from -28.2% to -39.9%.
- What does earnings yield mean?
- The company's annual profit as a percentage of its market price — the flip side of the P/E.
- How do you interpret earnings yield?
- Higher means more earnings per dollar invested. Easy to compare directly against bond yields to judge the relative attractiveness of equity.
- How does earnings yield compare across companies?
- Comparable across profitable companies and against fixed-income yields; undefined when earnings are negative.